Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes Research and Clinical Practice"
DOI: 10.1016/j.diabres.2020.108444
Abstract: In a nationwide study of 3818 charts from patients with fatal COVID-19, we found that geographical differences in Dipeptidyl peptidase 4 (DPP4) inhibitors use did not correlate with diabetes prevalence among COVID-19 deaths, thus not… read more here.
Keywords: dpp4 inhibitors; diabetes prevalence; among covid; covid deaths ... See more keywords